Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate

NCT03749733 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Bioequivalence

Interventions

DRUG: Estradiol 1.5 mg/nomegestrol acetate 2.5 mg (Reference Product)
DRUG: Estradiol 1.5 mg/nomegestrol acetate 2.5 mg (Test Product)

Sponsor

Grünenthal GmbH

Collaborators

[object Object]